Genomic Health Q3 Revenues up 12 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market Wednesday that its third-quarter revenues increased 12 percent year over year.

The Redwood City, Calif.-based molecular diagnostics firm said that revenues reached $58.6 million for the three months ended Sept. 30, up from $52.1 million, but short of the consensus Wall Street estimate of $59.9 million. Product revenues rose 13 percent year over year to $58.4 million from $51.7 million a year ago, while contract revenues dipped 25 percent to $277,000 from $397,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.